Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy

Post time 7 day(s) ago

journal：Cancer Cell

Authors：Shannon N. Geels; Alexander Moshensky; Rachel S. Sousa; Claire Murat; Matias A. Bustos; Benjamin L. Walker; Rima Singh; Stacey N. Harbour; Giselle Gutierrez; Michael Hwang; Thorsten R. Mempel; Casey T. Weaver; Qing Nie; Dave S.B. Hoon; Anand K. Ganesan; Shivashankar Othy; Francesco Marangoni

Published date：2024-6-

DOI：10.1016/j.ccell.2024.05.013

PDF link：https://www.sciencedirect.com/sc ... 535610824001818/pdf

Article link：http://dx.doi.org/10.1016/j.ccell.2024.05.013

Article Source：Elsevier BV。

Remark：

Post time 7 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy